| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/18/2003 | EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 06/18/2003 | EP1190087B1 Hydroxylation of compactin to pravastatin by micromonospora |
| 06/18/2003 | EP1171578B1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof |
| 06/18/2003 | EP0891427B1 Expression of hgv antigens and their use |
| 06/18/2003 | EP0821739B1 An adenovirus helper-virus system |
| 06/18/2003 | EP0815241B1 Identification and cloning of a mobile transposon from aspergillus |
| 06/18/2003 | EP0538404B1 Fibroblast growth factor receptors |
| 06/18/2003 | CN1425071A Mutant apre promoter |
| 06/18/2003 | CN1425068A Fungal transcriptional activator useful in methods for producing polypeptides |
| 06/18/2003 | CN1425063A Lactic acid bacteria overproducing exopolysaccharides |
| 06/18/2003 | CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene |
| 06/18/2003 | CN1424870A Nuclear transfer with selected donor cells |
| 06/18/2003 | CN1111605C Fermentative production of vitamin B6 |
| 06/18/2003 | CN1111429C Urease-based vaccine against HeIicobacter infection |
| 06/17/2003 | US6579975 Consensus phytases |
| 06/17/2003 | US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist |
| 06/17/2003 | US6579855 Adenovirus-mediated gene therapy |
| 06/17/2003 | US6579841 Variant EGIII-like cellulase compositions |
| 06/17/2003 | US6579716 Better emergence characteristics and improved seedling growth under low-light environments |
| 06/17/2003 | US6579699 Method for producing fermentative product and stress-resistant microorganism |
| 06/17/2003 | US6579695 Phosphopantetheinyl transferases and uses thereof |
| 06/17/2003 | US6579693 Comprising nucleic acids encoding human NADPH-cytochrome reductase and human cytochrome; inactivated genes; contacting a chemical compound with an enzyme preparation to determine the metabolites from the degradation of the compound |
| 06/17/2003 | US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor |
| 06/17/2003 | US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs |
| 06/17/2003 | US6579528 Vaccines; genetically engineering |
| 06/17/2003 | US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 06/17/2003 | CA2222128C Surface anchoring vector and system for foreign proteins thereof |
| 06/17/2003 | CA2129820C Dna sequences encoding novel growth/differentiation factors |
| 06/17/2003 | CA2123315C Therapeutic agents which are antagonists or partial agonists of human interleukin 4 |
| 06/12/2003 | WO2003048774A1 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors |
| 06/12/2003 | WO2003048148A2 Statin-like compounds |
| 06/12/2003 | WO2003047358A1 Cheese flavour ingredient and method of its production |
| 06/12/2003 | US20030110535 Transforming gene using enzyme; potatoes; discoloration inhibition |
| 06/12/2003 | US20030110519 Cognition activators, sleep disorders, eating disorders, psychological disorders |
| 06/12/2003 | US20030109693 Chondroitin polymerase and DNA encoding the same |
| 06/12/2003 | US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide |
| 06/12/2003 | US20030109567 Antitumor agent which comprises said compound or a physiologically acceptable salt thereof as an active ingredient. |
| 06/12/2003 | US20030109436 Wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. DNA sequence codes for cells |
| 06/12/2003 | US20030109430 Immunoassays for human and canine brain natriuretic peptide |
| 06/12/2003 | US20030109026 Genetically modified tumor-targeted bacteria with reduced virulence |
| 06/12/2003 | US20030109013 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid |
| 06/12/2003 | US20030109007 Process for producing N-acetylneuraminic acid |
| 06/12/2003 | US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids |
| 06/12/2003 | US20030109001 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies |
| 06/12/2003 | US20030108866 Peptide-nucleic acid (PNA) probes; amplification products; cervical scraping analysis/cancer diagnosis |
| 06/12/2003 | US20030108642 Penicillium funiculosum strain useful for the production of enzymes |
| 06/12/2003 | US20030108573 Phenol, water solvent extraction using a protease |
| 06/12/2003 | US20030108540 Inducing apoptosis in tissues; binding antibodies |
| 06/12/2003 | US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/12/2003 | US20030106655 Process for treating with enzyme |
| 06/12/2003 | CA2468905A1 Cheese flavour ingredient and method of its production |
| 06/11/2003 | EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody |
| 06/11/2003 | EP1318196A1 Amino acid producing strains belonging to the genus Escherichia and method for producing amino acid |
| 06/11/2003 | EP1317565A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 06/11/2003 | EP1317475A2 Peptides for use in culture media |
| 06/11/2003 | EP0851914B1 Purified mannanase from bacillus amyloliquefaciens and method of preparation |
| 06/11/2003 | EP0848755B1 Vegf-related protein |
| 06/11/2003 | EP0817838B1 Alkaline lipolytic enzyme |
| 06/11/2003 | EP0707641B1 An enzyme with protease activity |
| 06/11/2003 | EP0694075B1 Thermostable dna topoisomerase v |
| 06/11/2003 | EP0690873B1 Growth differentiation factor-8 |
| 06/11/2003 | EP0662086B1 Protein l and hybrid proteins thereof |
| 06/11/2003 | EP0638119B1 Chimeric receptor genes and cells transformed therewith |
| 06/11/2003 | EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 06/11/2003 | CN1423693A Method for the production of vitamin A |
| 06/10/2003 | US6576820 Rice cell transformed with a gene encoding the protein; useful as an ingredient in food and for preventing and treating arteriosclerosis and coronary heart diseases; lowers serum cholesterol |
| 06/10/2003 | US6576758 Nucleic acid constructs containing hybrid promoters |
| 06/10/2003 | US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell |
| 06/10/2003 | US6576455 Structure-based designed herbicide resistant products |
| 06/10/2003 | US6576451 (meth)acrylate endcapped polyether reaction product with a diisocyanate; use in bioremediation of dioxins, bisphenol a and in denitrification of sewage |
| 06/10/2003 | US6576450 Generating polyhydroxyalkanoates; obtain genetically cells which express enzymes associated with generation of polyhydroxyalanoates, incubate with 3-hydroxypropionate or 3-hydroxyvalerate, recover polyhydroxyalkonoates |
| 06/10/2003 | CA2159088C Metal removal from aqueous solution |
| 06/10/2003 | CA2121121C Preparation of recombinant borrelia proteins |
| 06/10/2003 | CA2081879C Monoclonal antibodies to polyacrylate polymers |
| 06/10/2003 | CA2065323C Isolation and purification of lung surfactant protein |
| 06/05/2003 | WO2003046193A2 PRODUCTION OF α-KETO BUTYRATE |
| 06/05/2003 | WO2003046192A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/05/2003 | WO2003046159A1 (r)-hydroxycarboxylic acid producing recombinant microorganism and process for preparing (r)-hydroxycarboxylic acid using the same |
| 06/05/2003 | WO2003046155A1 Ϝ-glutamylcysteine-producing yeast |
| 06/05/2003 | WO2003046154A1 Ϝ-glutamylcysteine-producing yeast and method of screening the same |
| 06/05/2003 | WO2003004656A9 Method for obtaining cells with new properties |
| 06/05/2003 | WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 06/05/2003 | WO2002060932A3 A serpin in bifidobacteria |
| 06/05/2003 | WO2002014478A3 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
| 06/05/2003 | WO2001064899A9 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 06/05/2003 | US20030106107 Genes encoding plant transcription factors |
| 06/05/2003 | US20030106100 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules |
| 06/05/2003 | US20030106093 Coleoptera resistant plants; biological pest control |
| 06/05/2003 | US20030105160 From 2-keto(gluconic acid or gulonic acid) uing heat sensitive microorganisms; acid catalyst cyclization |
| 06/05/2003 | US20030104578 Secreted in yeast; storage stability; microbiocides |
| 06/05/2003 | US20030104576 Methylation inhibitors; vaccines; viricides |
| 06/05/2003 | US20030104546 Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swollenins |
| 06/05/2003 | US20030104516 Protein kinase npk-110 |
| 06/05/2003 | US20030104444 Plasmids for use as tools in treatment and prevention of nervous system, cancer and viral disorders |
| 06/05/2003 | US20030104405 Method of differentiating beer yeast |
| 06/05/2003 | US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer |
| 06/05/2003 | US20030104379 HY2 family of bilin reductases |
| 06/05/2003 | US20030104302 Construct and method for making it |
| 06/05/2003 | US20030104064 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 06/05/2003 | US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection |